-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Sunita Venkateswaran, Brenda Banwell
Clinical Trail Methodology: Clinical Investigation
-
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Sunita Venkateswaran, Brenda Banwell
Clinical Trail Methodology: Clinical Investigation
-
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Sunita Venkateswaran, Brenda Banwell
Clinical Trail Methodology: Clinical Investigation
-
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Sunita Venkateswaran, Brenda Banwell
Clinical Trail Methodology: Clinical Investigation
-
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Sunita Venkateswaran, Brenda Banwell
Clinical Trail Methodology: Clinical Investigation
-
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Sunita Venkateswaran, Brenda Banwell
Clinical Trail Methodology: Clinical Investigation
-
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Sunita Venkateswaran, Brenda Banwell
Clinical Trail Methodology: Clinical Investigation
-
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Sunita Venkateswaran, Brenda Banwell
Clinical Trail Methodology: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation